Showing results (111-120 of 153) with videos related to

Sort By:
Pageof 16
JCO Precision Oncology|August 21, 2018
Heterogeneity and Coexistence of T790M and T790 Wild-Type Resistant Subclones Drive Mixed Response to Third-Generation Epidermal Growth Factor Receptor Inhibitors in Lung CancerZofia Piotrowska, Mehlika Hazar-Rethinam, Coleen Rizzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 31, 2018
Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical OncologyJohn Heymach, Lada Krilov, Anthony Alberg, et al.
Cancer Cell|December 19, 2012
Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer modelsRyan B Corcoran, Katherine A Cheng, Aaron N Hata, et al.
Cancer Discovery|October 29, 2013
mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1Anthony C Faber, Erin M Coffee, Carlotta Costa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 29, 2025
MAPK Pathway Mutations Emerge in Mutant-IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the Interferon ResponseJinkai Wan, Hatice Duygu Saatcioglu, Haley Ellis, et al.
The Oncologist|August 22, 2020
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric CancersSurendra Pal Chaudhary, Eunice L Kwak, Katie L Hwang, et al.
JCO Oncology Practice|May 27, 2021
Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal CancerKatie Kanter, Madeleine Fish, Gianluca Mauri, et al.
Cancer Discovery|February 13, 2018
Combined BRAF, EGFR, and MEK Inhibition in Patients with <i>BRAF</i><sup>V600E</sup>-Mutant Colorectal CancerRyan B Corcoran, Thierry André, Chloe E Atreya, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
A unique interplay of access and selection shapes peritoneal metastasis evolution in colorectal cancerEmma Ce Wassenaar, Alexander N Gorelick, Wei-Ting Hung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung CancerJulia K Rotow, Philippe Gui, Wei Wu, et al.
Pageof 16